Rara reacción adversa por sirolimus. A propósito de un caso

Spiegel, 2001, Terapia de sustitución renal: diálisis y trasplante, 168 Pallardo, 2003, Complicaciones a largo plazo del trasplante renal, 909 Brazelton, 1996, Molecular mechanisms of action of new xenobiotic immunosuppressive drugs: tacrolimus, sirolimus, mycophenolate mofetil and leflunomide, Curr Opin Immunol, 8, 710, 10.1016/S0952-7915(96)80090-2 Hong, 1999, Use of anti-CD25 monoclonal antibody in combination with rapamicin to eliminate cyclosporine treatment during the induction phase of immunosuppresion, Transplantation, 68, 701, 10.1097/00007890-199909150-00018 Data on File, Wyeth-Ayerst Pharmaceuticals. A double-blind, comparative study of the effect of two dose levles of sirolimus versus azatioprine, administered concomitantly with standard immunosupressive therapy in renal allograft recipients: 6- month final report (protocol 0468E1-301-US) GMR-27593-1998. Data on File, Wyeth-Ayerst Pharmaceuticals. Ascending single dose safety, tolerance and pharmaokinetic, study of oral sirolimus solution in pediatric patients with stable chronic renal failure receiving hemodialysis or peritoneal dialysis: final report (protocol 0468E1-147-US). GMR-31333, 1998. Data on File, Wyeth-Ayerst Pharmaceuticals. Pharmacokinetics of sirolimus in patients with chronic hepatic impairment and in healthy adults: final report (protocol 0468E1-134-US). GMR-31333, 1998. Groth, 1999, Sirolimus(Rapamycin) based therapy in human renaltransplantation, Transplantation, 67, 1036, 10.1097/00007890-199904150-00017 Kreis, 1999, Sirolimus (Rapamycin) based therapy inhuman renal transplantation, Transplantation, 67, 1036, 10.1097/00007890-199904150-00017 Kreis, 2000, Sirolimus(Rapamycin) in association with mycophenolatemofetil induction for the prevention of acutegraft rejection in renal allograft recipients, Transplantation, 69, 1252, 10.1097/00007890-200004150-00009 Hong, 2001, A calcineurin antagonist-free induction immunosuppression strategy for delayed graft function, in kidney transplantation. Transplantation Proceedings, 33, 1271, 10.1016/S0041-1345(00)02474-X Johnson, 2001, Sirolimusallows early cyclosporine withdrawal in renaltransplantation resulting in improved renal function and lower blood pressure, Transplantation, 72, 777, 10.1097/00007890-200109150-00007 Weir, 2001, Impact of inmunosupprensive regimen on posttransplant diabetes mellitus, Transplanatation Proceedings, 33, 23S, 10.1016/S0041-1345(01)02231-X Morelon, 2001, Sirolimus: a new promising immunosuppressive drug. Towards a rationale for itsuse in renal transplantation, Nephrol Dial Transplant, 16, 18, 10.1093/ndt/16.1.18 MacDonald, 2001, A worldwide, phase III, randomined, controlled, safety and efficacy study of asirolimus/cyclosporine regimen for preventionof acute rejection in recipients of primary mismatched renal allografts, Transplantation, 72, 271, 10.1097/00007890-200101270-00019 Kahan, 2000, Efficacy of sirolimus comparedwith azathioprine for reduction of acute renalallograft rejection: a randomised multicentrestudy. The Rapamune US Study Group, Lancet, 356, 194, 10.1016/S0140-6736(00)02480-6 MacDonald, 2000, Management strategies for nephrotoxicity, Transplantation, 69, S831, 10.1097/00007890-200006271-00008 Flechner, 2002, Kidney transplantation without calcineurin inhibitor drugs: Prospective randomizedtrial of sirolimus versus cyclosporine, Transplantation, 74, 1070, 10.1097/00007890-200210270-00002 Hong, 2002, A calcineurin antagonist-free induction strategy for immunosuppression in cadaveric kidney transplant recipients atrisk for delayed graft function, Transplantation, 72, 1320 Guba, 2002, Rpamycin inhibits primary and metastatictumor growth by antiangiogenesis: involvement of vascular endothelial growth factor, Nature Med, 8, 128, 10.1038/nm0202-128 Smith, 2003, Delayed graft function and cast nephropathy associated with tacrolimus plus rapamycin use, J Am Soc Nephrol, 14, 1037, 10.1097/01.ASN.0000057542.86377.5A Davis, 2003, Sirolimus delays renal allograft recovery, Am J Transplant, 3, 363, 10.1034/j.1600-6143.2003.00116.x McTaggart, 2003, Sirolimus prolongs recovery from delayed graft function after cadaveric renal transplantation, Am J Transplant, 3, 416, 10.1034/j.1600-6143.2003.00078.x